Renee Pellerin
LightNews LightNews
reneepellerin.bsky.social
Renee Pellerin
@reneepellerin.bsky.social
320 followers 290 following 10 posts
Canadian health journalist, author of Conspiracy of Hope, the Truth about Breast Cancer Screening, Goose Lane Editions.
Posts Replies Media Videos
Reposted by Renee Pellerin
healthydebate.bsky.social
When advocacy overrides science, who benefits?

healthydebate.ca/2025/07/topi...
When advocacy overrides science, who benefits? - Healthy Debate
When it comes to Canada's health policies, are decisions being guided by science or the pressures of advocacy and lobbying efforts?
healthydebate.ca
July 17, 2025 at 12:22 AM
reneepellerin.bsky.social
healthydebate.ca/2025/07/topi...
When advocacy overrides science, who benefits? - Healthy Debate
When it comes to Canada's health policies, are decisions being guided by science or the pressures of advocacy and lobbying efforts?
healthydebate.ca
July 16, 2025 at 7:45 PM
reneepellerin.bsky.social
Family docs and female patients, you may want to read this great article by physician Susan Bewley regarding everything you need to know about mammography screening. It's clear, succinct, and a quick read.
t.co/PhseuYwIJm
https://archive.md/HP29s
t.co
February 25, 2025 at 5:36 PM
reneepellerin.bsky.social
AI assisted screening found 6.4 breast cancers per 1000 screens, while non-AI assisted screening found 5.0 per 1000. But it found significantly more in situ cancers, mainly DCIS, raising overdiagnosis concerns.
www.thelancet.com/journals/lan...
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, ...
The findings suggest that AI contributes to the early detection of clinically relevant breast cancer and reduces screen-reading workload without increasing false positives.
www.thelancet.com
February 5, 2025 at 6:43 PM
reneepellerin.bsky.social
Should we stop calling DCIS cancer?https://www.nytimes.com/2025/01/28/health/cancer-diagnosis-language.html?unlocked_article_code=1.sk4.3bEA.l3jVQNT8cKTq&smid=bs-share
When ‘Cancer’ Gets in the Way of Treatment (Gift Article)
Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.
www.nytimes.com
January 28, 2025 at 5:10 PM
reneepellerin.bsky.social
Happy to be discussing mammography screening in a live Facebook event this coming Friday.
www.facebook.com/share/15coZz...
Redirecting...
www.facebook.com
January 13, 2025 at 9:57 PM
reneepellerin.bsky.social
No evidence that reducing reducing screening results in more advanced breast cancers. jamanetwork.com/journals/jam...
USPSTF Screening Guideline Changes and Breast Cancer Incidence
This cohort study of women with breast cancer investigates cancer stage at diagnosis and surgical treatment before and after the 2009 US Preventive Services Task Force (USPSTF) guideline changes.
jamanetwork.com
January 12, 2025 at 9:07 PM
reneepellerin.bsky.social
Research challenging what we usually hear about breast screening. healthjournalism.org/blog/2025/01...
Less screening, fewer cases: What our audiences should know about breast cancer rates
A recent study found that fewer breast cancer screenings did not lead to a significant increase in more advanced cancers over 15 years.
healthjournalism.org
January 11, 2025 at 10:53 PM
reneepellerin.bsky.social
Shelley Hwang's important research on DCIS - monitoring instead of surgery etc. time.com/7201610/brea...
Some Early Forms of Breast Cancer May Not Need Treatment, Study Says
A long-awaited study offers hope to women with early stage breast cancer.
time.com
December 13, 2024 at 3:13 PM
reneepellerin.bsky.social
More from the DCIS Comet trial in JAMA
jamanetwork.com/journals/jam...
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ
This secondary analysis of the COMET randomized clinical trial examines patient-reported outcomes at baseline and over time in patients with low-risk ductal carcinoma in situ randomized to receive eit...
jamanetwork.com
December 13, 2024 at 3:06 PM
reneepellerin.bsky.social
Early results from the important COMET study by Dr. Shelley Hwang, regarding alternative approach to DCIS.
jamanetwork.com/journals/jam...
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ
This randomized noninferiority trial assesses the effect of a strategy of active monitoring vs guideline-concordant care on 2-year risk of ipsilateral invasive breast cancer among women with low-risk ...
jamanetwork.com
December 13, 2024 at 3:00 PM